Recent Quarter Total Invested
$1.52 B
Recent Quarter Institutional Ownership Percentage
92.84%
Total Invested of Last Quarter
$1.36 B
Ownership Percentage of Last Quarter
118.39%
Nurix Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.18 M | $161.37 M | 100.00% | 9.87% |
| REDMILE GROUP, LLC | 11/14/2024 | 4.28 M | $96.19 M | -3.22% | 5.88% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 3.88 M | $87.23 M | 0.00% | 5.33% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 3.87 M | $86.92 M | -3.09% | 5.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 3.48 M | $78.24 M | 8.75% | 4.78% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.07 M | $68.96 M | 8.25% | 4.22% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 2.55 M | $57.26 M | 16.39% | 3.50% |
| STATE STREET CORP | 11/14/2024 | 2.37 M | $53.28 M | -12.45% | 3.26% |
| ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 2.22 M | $49.80 M | -4.60% | 3.05% |
| MORGAN STANLEY | 11/14/2024 | 1.88 M | $42.21 M | -5.59% | 2.58% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.79 M | $40.19 M | 52.41% | 2.46% |
| COMMODORE CAPITAL LP | 11/14/2024 | 1.65 M | $37.08 M | 100.00% | 2.27% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.53 M | $34.41 M | 47.14% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.45 M | $32.54 M | 9.56% | 1.99% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.29 M | $28.89 M | 0.20% | 1.77% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 1.07 M | $23.95 M | -48.16% | 1.46% |
| CANDRIAM S.C.A. | 11/13/2024 | 1.06 M | $23.86 M | -8.79% | 1.46% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 860,399 | $19.33 M | -5.66% | 1.18% |
| WASATCH ADVISORS LP | 11/14/2024 | 708,377 | $15.92 M | -17.45% | 0.97% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 673,554 | $15.13 M | -31.35% | 0.93% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 568,264 | $12.77 M | -2.61% | 0.78% |
| BOXER CAPITAL, LLC | 11/14/2024 | 563,067 | $12.65 M | 100.00% | 0.77% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 553,251 | $12.43 M | 100.00% | 0.76% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/07/2024 | 552,602 | $12.41 M | 100.00% | 0.76% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 513,221 | $11.53 M | 10.49% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 511,720 | $11.50 M | -17.92% | 0.70% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 501,569 | $11.27 M | -16.84% | 0.69% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 438,971 | $9.86 M | -7.52% | 0.60% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 425,000 | $9.55 M | -15.00% | 0.58% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 420,000 | $9.44 M | 0.26% | 0.58% |
| INVESCO LTD. | 11/12/2024 | 413,340 | $9.29 M | 13.15% | 0.57% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 355,602 | $7.99 M | -17.74% | 0.49% |
| LORD, ABBETT & CO. LLC | 11/14/2024 | 350,640 | $7.88 M | 100.00% | 0.48% |
| WOODLINE PARTNERS LP | 11/14/2024 | 336,879 | $7.57 M | 11.59% | 0.46% |
| PATIENT SQUARE CAPITAL LP | 11/14/2024 | 325,789 | $7.32 M | 100.00% | 0.45% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 314,762 | $7.07 M | 0.00% | 0.43% |
| BESSEMER GROUP INC | 11/12/2024 | 306,053 | $6.88 M | 0.02% | 0.42% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 300,000 | $6.74 M | 72.03% | 0.41% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 290,000 | $6.52 M | 0.00% | 0.40% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 260,000 | $5.84 M | -40.98% | 0.36% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 246,400 | $5.54 M | -23.95% | 0.34% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 241,048 | $5.42 M | -28.04% | 0.33% |
| WESTHILL FINANCIAL ADVISORS, INC. | 10/18/2024 | 238,333 | $5.36 M | -15.88% | 0.33% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 221,718 | $4.98 M | -63.02% | 0.30% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 214,728 | $4.82 M | 125.03% | 0.30% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 203,015 | $4.56 M | -0.13% | 0.28% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 200,000 | $4.49 M | 33.33% | 0.27% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 180,000 | $4.04 M | 404.99% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 175,266 | $3.94 M | -16.20% | 0.24% |
| EAM INVESTORS, LLC | 11/13/2024 | 174,760 | $3.93 M | 0.39% | 0.24% |
Nurix Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NRIX shares?
During the previous two years, 204 institutional investors and hedge funds held shares of Nurix Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 7.18 M
Redmile Group, LLC: 4.28 M
BAKER BROS. ADVISORS LP: 3.88 M
Deep Track Capital, LP: 3.87 M
WELLINGTON MANAGEMENT GROUP LLP: 3.48 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.07 M
-
What percentage of Nurix Therapeutics, Inc. stock is owned by institutional investors?
92.84% of Nurix Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at NRIX ?
Institutional investors have bought a total of 77.57 M shares in the last 24 months. This purchase volume represents approximately $1.71 B in transactions.